The expression of transforming growth factor-β and interleukin-1β mRNA and the response to 1,25(OH)2D3, 17β-estradiol, and testosterone is age dependent in primary cultures of mouse-derived osteoblasts in vitro

被引:26
作者
Wang, XS
Schwartz, Z
Yaffe, P
Ornoy, A
机构
[1] Hebrew Univ Jerusalem, Hadassah Med Sch, Lab Teratol, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Dept Periodont, IL-91120 Jerusalem, Israel
关键词
osteoblasts; cytokine; hormones; age; expression; in situ hybridization;
D O I
10.1385/ENDO:11:1:13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to examine the hypothesis that primary cultures of osteoblasts obtained from bones of young animals respond to hormones better than cell cultures obtained from old animals. We studied in cultured osteoblastic cells the effects of 1,25(OH)(2)D-3 and sex steroid hormones on several mouse osteoblastic phenotypic expressions including transforming grow th factor-beta (TGF-beta) and interleukin-1 beta (IL-1 beta) mRNAs. Second passages of long bone-derived osteoblastic cells from young donors (5-12 wk) and old donors (10-12 mo old) were used for this study. The cells obtained from old animals had decreased ALP activity and cAMP compared with cells obtained from young animals with no change in collagen production and mineralization. The addition of 17 beta-estradiol and testosterone increased ALP activity and mineralization in the cultured cells from both age groups and collagen production in cells obtained from old mice. Using in situ hybridization IL-1 beta and TGF-beta mRNA expression was observed to be higher in the osteoblasts from young than from old donors, 1,25(OH)(2)D-3 increased IL-1 beta mRNA expression in the cells derived from young mice, Testosterone and 17 beta-estradiol inhibited IL-1 beta mRNA expression only in cells derived from young mice. Sex steroid hormones did not change TGF-beta mRNA expression in any of the cell lines, but 1,25(OH)(2)D-3 increased its expression in cells derived from old donors. The results of the present study indicate that cells obtained from old mice are generally less active than those obtained from young animals.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 51 条
[21]  
KATZBURG S, 1997, 11 ISR MED WEEK JER
[22]  
KEETING PE, 1991, J BONE MINER RES, V6, P827
[23]   PERSISTENT BONE-SPARING EFFECT OF INTERLEUKIN-1 RECEPTOR ANTAGONIST - A HYPOTHESIS ON THE ROLE OF IL-1 IN OVARIECTOMY-INDUCED BONE LOSS [J].
KIMBLE, RB ;
KITAZAWA, R ;
VANNICE, JL ;
PACIFICI, R .
CALCIFIED TISSUE INTERNATIONAL, 1994, 55 (04) :260-265
[24]   INTERLEUKIN-1 RECEPTOR ANTAGONIST DECREASES BONE LOSS AND BONE-RESORPTION IN OVARIECTOMIZED RATS [J].
KIMBLE, RB ;
VANNICE, JL ;
BLOEDOW, DC ;
THOMPSON, RC ;
HOPFER, W ;
KUNG, VT ;
BROWNFIELD, C ;
PACIFICI, R .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (05) :1959-1967
[25]   IN-VITRO PRODUCTION OF CYTOKINES BY BONE SURFACE-DERIVED OSTEOBLASTIC CELLS IN NORMAL AND OSTEOPOROTIC POSTMENOPAUSAL WOMEN - RELATIONSHIP WITH CELL-PROLIFERATION [J].
MARIE, PJ ;
HOTT, M ;
LAUNAY, JM ;
GRAULET, AM ;
GUERIS, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (03) :824-830
[26]   ROLE OF CYTOKINES IN BONE-RESORPTION [J].
MUNDY, GR .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, 53 (04) :296-300
[27]   THE EFFECTS OF CYTOKINES AND GROWTH-FACTORS ON OSTEOBLASTIC CELLS [J].
MUNDY, GR ;
BOYCE, B ;
HUGHES, D ;
WRIGHT, K ;
BONEWALD, L ;
DALLAS, S ;
HARRIS, S ;
GHOSHCHOUDHURY, N ;
CHEN, D ;
DUNSTAN, C ;
IZBICKA, E ;
YONEDA, T .
BONE, 1995, 17 (02) :S71-S75
[28]  
NASATZKY E, 1994, ENDOCRINE, V2, P207
[29]   SEX-DEPENDENT EFFECTS OF 17-BETA-ESTRADIOL ON CHONDROCYTE DIFFERENTIATION IN CULTURE [J].
NASATZKY, E ;
SCHWARTZ, Z ;
BOYAN, BD ;
SOSKOLNE, WA ;
ORNOY, A .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (02) :359-367
[30]   AGE-RELATED DECREASES IN INSULIN-LIKE GROWTH-FACTOR-I AND TRANSFORMING GROWTH-FACTOR-BETA IN FEMORAL CORTICAL BONE FROM BOTH MEN AND WOMEN - IMPLICATIONS FOR BONE LOSS WITH AGING [J].
NICOLAS, V ;
PREWETT, A ;
BETTICA, P ;
MOHAN, S ;
FINKELMAN, RD ;
BAYLINK, DJ ;
FARLEY, JR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1011-1016